$VISM
VISIUM TECHNOLOGIES, INC. Stock $vism

$vism Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000165495422013289 Filed on October 04, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022
Revenue	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$359.6K	$555.0K	$4.316M
YoY Change	-70.03%	-28.94%	11.27%
% of Gross Profit
Research & Development	$54.89K	$86.68K	$361.3K
YoY Change	-50.28%	-24.61%	39.95%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$414.5K	$641.6K	$4.677M
YoY Change	-68.37%	-28.38%	13.06%
Operating Profit	-$414.5K		-$4.677M
YoY Change	-68.37%		13.74%
Interest Expense	$129.7K	-$129.3K	$705.1K
YoY Change	-125.67%	-116.28%	105.56%
% of Operating Profit
Other Income/Expense, Net	-$623.3K		-$516.0K
YoY Change	23.33%
Pretax Income	-$1.038M	-$583.0K	-$5.194M
YoY Change	-42.85%	-185.03%	53.95%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$1.038M	-$583.0K	-$5.194M
YoY Change	-42.85%	-185.03%	53.95%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$358.3K	-$225.4K	-$2.073M
COMMON SHARES
Basic Shares Outstanding	2.902M shares	3.904B shares
Diluted Shares Outstanding	2.897M shares		2.505M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$22.52K	$137.0K	$137.0K
YoY Change	-97.75%	9.44%	9.44%
Cash & Equivalents	$22.52K	$137.0K
Short-Term Investments
Other Short-Term Assets	$52.50K	$0.00	$0.00
YoY Change	38.45%	-100.0%	-100.0%
Inventory
Prepaid Expenses	$52.50K	$0.00
Receivables
Other Receivables
Total Short-Term Assets	$75.02K	$137.0K	$137.0K
YoY Change	-92.77%	-24.14%	-24.14%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$75.02K	$137.0K	$137.0K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$75.02K	$137.0K	$137.0K
YoY Change	-92.77%	-24.14%	-24.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$647.1K	$596.5K	$596.5K
YoY Change	46.06%	40.08%	40.08%
Accrued Expenses	$1.260M	$1.019M	$1.019M
YoY Change	13.62%	-1.87%	-1.87%
Deferred Revenue
YoY Change
Short-Term Debt	$1.692M	$1.279M	$1.279M
YoY Change	89.73%	-6.53%	-6.53%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.677M	$2.931M	$2.931M
YoY Change	38.87%	-2.89%	-2.89%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$0.00	$0.00
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.677M	$2.931M	$2.931M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$3.677M	$2.931M	$2.931M
YoY Change	38.87%	-2.89%	-2.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$57.60M	-$56.56M
YoY Change		10.11%
Common Stock	$290.00	$288.00
YoY Change		-99.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.601M	-$2.794M	-$2.794M
YoY Change
Total Liabilities & Shareholders Equity	$75.02K	$137.0K	$137.0K
YoY Change	-92.77%	-24.14%	-24.14%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	-$1.038M	-$583.0K	-$5.194M
YoY Change	-42.85%	-185.03%	53.95%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$167.5K	-$482.0K	-$2.225M
YoY Change	-67.19%	154.32%	180.65%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.500M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$53.00M	266.4K	$2.236M
YoY Change	3726.71%	590.16%	151.97%
NET CHANGE
Cash From Operating Activities	-$167.5K	-482.0K	-$2.225M
Cash From Investing Activities
Cash From Financing Activities	$53.00M	266.4K	$2.236M
Net Change In Cash	$52.83M	-215.6K	$11.82K
YoY Change	5940.77%	42.85%	-87.54%
FREE CASH FLOW
Cash From Operating Activities	-$167.5K	-$482.0K	-$2.225M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q2	us-gaap	Cash Cash	125166	usd
CY2021Q4	dei	Entity Public Float EntityPublicFloat	8550027	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2901590	shares
CY2022	dei	Auditor Name AuditorName	Assurance Dimensions, Inc.
CY2022	dei	Auditor Firm AuditorFirmId	5036
CY2022	dei	Auditor Location AuditorLocation	Margate, Florida
CY2022Q2	us-gaap	Cash Cash	136990	usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001082733
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2020Q2	us-gaap	Interest Payable Current InterestPayableCurrent	677857	usd
CY2022	vism	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2022	vism	Average Price Per Share Of Stock Option AveragePricePerShareOfStockOption	0.015
CY2022	vism	Options To Purchase Vested Shares OptionsToPurchaseVestedShares	2222	shares
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-25753
CY2022	dei	Entity Registrant Name EntityRegistrantName	VISIUM TECHNOLOGIES, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0449667
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	4094 MAJESTIC LANE
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	SUITE 360
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Fairfax
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	22033
CY2022	dei	City Area Code CityAreaCode	703
CY2022	dei	Local Phone Number LocalPhoneNumber	273-0383
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	404712	usd
CY2021Q2	us-gaap	Interest Payable Current InterestPayableCurrent	366149	usd
CY2022Q2	vism	Convertible Notes Payable To Asc Recap Llc ConvertibleNotesPayableToAscRecapLlc	0	usd
CY2021Q2	vism	Convertible Notes Payable To Asc Recap Llc ConvertibleNotesPayableToAscRecapLlc	147965	usd
CY2022Q2	vism	Convertible Notes Payable Current1 ConvertibleNotesPayableCurrent1	1074487	usd
CY2021Q2	vism	Convertible Notes Payable Current1 ConvertibleNotesPayableCurrent1	809195	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	0	usd
CY2021Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	18252	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	288	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53749386	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-56558552	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2793558	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	136990	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4316191	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3879158	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	361298	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	258168	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	4677489	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	4137326	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4677489	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4112326	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1119	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1844460	usd
CY2022	vism	Derivative Liability Expense DerivativeLiabilityExpense	0	usd
CY2021	vism	Derivative Liability Expense DerivativeLiabilityExpense	1059282	usd
CY2022	us-gaap	Interest Expense InterestExpense	705075	usd
CY2021	us-gaap	Interest Expense InterestExpense	442171	usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	187930	usd
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-28863	usd
CY2022	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	usd
CY2021	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	578408	usd
CY2022	vism	Warrant Exercise Expense WarrantExerciseExpense	0	usd
CY2021	vism	Warrant Exercise Expense WarrantExerciseExpense	211411	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-516026	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-738867	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5193515	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3373459	usd
CY2022	vism	Basic And Diluted BasicAndDiluted	2505011	shares
CY2021	vism	Basic And Diluted BasicAndDiluted	1467777	shares
CY2022	vism	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-2.07
CY2021	vism	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-2.30
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-3380760	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	2809000	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	354000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	391039	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	133029	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	211411	usd
CY2021	vism	Amortization Of Deferred Compensation AmortizationOfDeferredCompensation	18553	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3373459	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-2837187	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1173800	usd
CY2022	vism	Shares Issued As Compensation To Employees Amount SharesIssuedAsCompensationToEmployeesAmount	762837	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	241800	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	831047	usd
CY2022	vism	Shares Issued Pursuant To Sale Of Common Stock Amount SharesIssuedPursuantToSaleOfCommonStockAmount	1500000	usd
CY2022	vism	Commitment Shares Issued Pursuant To Convertible Notes Payable Amount CommitmentSharesIssuedPursuantToConvertibleNotesPayableAmount	236567	usd
CY2022	vism	Benefical Conversion Feature With Convertible Debt BeneficalConversionFeatureWithConvertibleDebt	239564	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	108000	usd
CY2022	vism	Amortization Of Deferred Compensation AmortizationOfDeferredCompensation	143529	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5193515	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2793558	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5193515	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3373459	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	571081	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	305499	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2178437	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3163000	usd
CY2022	vism	Gain Loss On Debt Settlement GainLossOnDebtSettlement	187930	usd
CY2021	vism	Gain Loss On Debt Settlement GainLossOnDebtSettlement	607271	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1119	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1844460	usd
CY2022	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	143529	usd
CY2021	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	0	usd
CY2022	vism	Amortization Of Prepaid Expense AmortizationOfPrepaidExpense	55417	usd
CY2021	vism	Amortization Of Prepaid Expense AmortizationOfPrepaidExpense	0	usd
CY2022	vism	Warrant Conversion Expense WarrantConversionExpense	0	usd
CY2021	vism	Warrant Conversion Expense WarrantConversionExpense	211411	usd
CY2022	vism	Derivative Liability Expense DerivativeLiabilityExpense	0	usd
CY2021	vism	Derivative Liability Expense DerivativeLiabilityExpense	1059282	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	169538	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	445850	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-57940	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	20000	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	97926	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	96007	usd
CY2022	vism	Increase Decrease On Discount On Notes IncreaseDecreaseOnDiscountOnNotes	0	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	55417	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
CY2021	vism	Increase Decrease On Discount On Notes IncreaseDecreaseOnDiscountOnNotes	-213082	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2224572	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-792640	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	vism	Advance From Officers AdvanceFromOfficers	102340	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1076400	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	838595	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	225000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1500000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	225000	usd
CY2021	vism	Commitment Shares Issued Pursuant To Convertible Notes Payable CommitmentSharesIssuedPursuantToConvertibleNotesPayable	0	usd
CY2022	vism	Repayment Of Convertible Notes Payable RepaymentOfConvertibleNotesPayable	-115000	usd
CY2021	vism	Repayment Of Convertible Notes Payable RepaymentOfConvertibleNotesPayable	-73700	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2236400	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	887555	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11824	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	94915	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	125166	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	30251	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	136990	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	125166	usd
CY2022	us-gaap	Interest Paid InterestPaid	30231	usd
CY2021	us-gaap	Interest Paid InterestPaid	39755	usd
CY2021	vism	Shares Issued Pursuant To Settlement Of Litigation SharesIssuedPursuantToSettlementOfLitigation	0	usd
CY2021	vism	Beneficial Conversion Feature With Convertible Debt BeneficialConversionFeatureWithConvertibleDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	831047	usd
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	188460	usd
CY2022	vism	Commitment Shares Issued Pursuant To Convertible Notes Payable CommitmentSharesIssuedPursuantToConvertibleNotesPayable	236567	usd
CY2022	vism	Shares Issued Pursuant To Settlement Of Litigation SharesIssuedPursuantToSettlementOfLitigation	108000	usd
CY2022	vism	Beneficial Conversion Feature With Convertible Debt BeneficialConversionFeatureWithConvertibleDebt	239564	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q2	vism	Common Stock Shares Authorized To Be Issued CommonStockSharesAuthorizedToBeIssued	10000000000	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5193515	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2224572	usd
CY2022Q2	vism	Working Capital Deficit WorkingCapitalDeficit	-2793558	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions used in Cox, Ross & Rubinstein Binomial Tree stock-based compensation and derivative liabilities valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate and in the valuation allowance of deferred tax assets.</p>
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1464777	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	482472	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	105244	shares
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is subject to a concentration of credit risk from cash.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s cash account is held at a financial institution and is insured by the Federal Deposit Insurance Corporation, or FDIC, up to $250,000.</p>
CY2022Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	35297	usd
CY2022Q2	vism	Convertible Notes Payables ConvertibleNotesPayables	31350	usd
CY2021Q2	vism	Convertible Notes Payables ConvertibleNotesPayables	115047	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	831047	usd
CY2020Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	438663	usd
CY2021	vism	Increase Due To Issuance Of Convertible Note IncreaseDueToIssuanceOfConvertibleNote	1059282	usd
CY2021	vism	Derivative Liability Adjsutments As A Result Of Note Discounts DerivativeLiabilityAdjsutmentsAsAResultOfNoteDiscounts	530896	usd
CY2021	vism	Gain Loss On Change In Fair Value Of Derivative Liability GainLossOnChangeInFairValueOfDerivativeLiability	-1844460	usd
CY2021Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	184381	usd
CY2022	vism	Derivative Liability Reduced As A Result Of Debt Settlement DerivativeLiabilityReducedAsAResultOfDebtSettlement	-147965	usd
CY2022	vism	Gain Loss On Change In Fair Value Of Derivative Liability GainLossOnChangeInFairValueOfDerivativeLiability	-1119	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	35297	usd
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	11348	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	11348	shares
CY2022	vism	Incremental Common Shares Attributable To Common Stock Option IncrementalCommonSharesAttributableToCommonStockOption	2222	shares
CY2021	vism	Incremental Common Shares Attributable To Common Stock Option IncrementalCommonSharesAttributableToCommonStockOption	11852	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	5049	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	9011	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3006102	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1602232	shares
CY2022	vism	Total Reverse Stock Split Outstanding Common Shares TotalReverseStockSplitOutstandingCommonShares	2896396	shares
CY2022	vism	Description Of Reverse Stock Split Effect DescriptionOfReverseStockSplitEffect	This action also reduced the number of Authorized common shares of the Company from 10,000,000,000 to 1,000,000,000
CY2022	vism	Debt Conversion Converted Instrument Principal DebtConversionConvertedInstrumentPrincipal	772797	usd
CY2022	vism	Amount Converted Interest AmountConvertedInterest	56000	usd
CY2022	vism	Conversion Expense ConversionExpense	2250	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2505011	shares
CY2022	vism	Prepaid License Fee PrepaidLicenseFee	70000	usd
CY2022	vism	Conversion Of Warrant Ranging ConversionOfWarrantRanging	from $0.0055 to $0.02 per share exercise price of the warrants
CY2022	vism	Recognition Of Gane Loss RecognitionOfGaneLoss	1119	usd
CY2021	vism	Recognition Of Gane Loss RecognitionOfGaneLoss	1844460	usd
CY2022Q2	vism	Warrants Fair Value WarrantsFairValue	3947	usd
CY2021Q2	vism	Warrants Fair Value WarrantsFairValue	69334	usd
CY2022Q2	vism	Derivative Liabilities Fair Value Assumptions Market Price DerivativeLiabilitiesFairValueAssumptionsMarketPrice	1.755
CY2021Q2	vism	Derivative Liabilities Fair Value Assumptions Market Price DerivativeLiabilitiesFairValueAssumptionsMarketPrice	8.10
CY2022	vism	Derivative Liabilities Fair Value Assumptions Expected Dividend Rate DerivativeLiabilitiesFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	vism	Derivative Liabilities Fair Value Assumptions Expected Dividend Rate DerivativeLiabilitiesFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q2	vism	Convertible Notes Payable1 ConvertibleNotesPayable1	1487431	usd
CY2021Q2	vism	Convertible Notes Payable1 ConvertibleNotesPayable1	1205228	usd
CY2022Q2	vism	Discount On Convertible Notes Payable DiscountOnConvertibleNotesPayable	-412944	usd
CY2021Q2	vism	Discount On Convertible Notes Payable DiscountOnConvertibleNotesPayable	-396033	usd
CY2022Q2	vism	Convertible Notes Payable To Related Parties Current ConvertibleNotesPayableToRelatedPartiesCurrent	1074487	usd
CY2021Q2	vism	Convertible Notes Payable To Related Parties Current ConvertibleNotesPayableToRelatedPartiesCurrent	809195	usd
CY2022Q2	vism	Convertible Notes Payable To Asc Recap ConvertibleNotesPayableToAscRecap	0	usd
CY2021Q2	vism	Convertible Notes Payable To Asc Recap ConvertibleNotesPayableToAscRecap	147965	usd
CY2022Q2	vism	Convertible Debt2 ConvertibleDebt2	1074487	usd
CY2021Q2	vism	Convertible Debt2 ConvertibleDebt2	957160	usd
CY2022Q2	vism	Convertible Notes Payable2 ConvertibleNotesPayable2	1487431	usd
CY2021Q2	vism	Convertible Notes Payable2 ConvertibleNotesPayable2	1205228	usd
CY2013Q3	vism	Principal Amount PrincipalAmount	25000	usd
CY2014Q2	vism	Principal Amount PrincipalAmount	125000	usd
CY2022	vism	Description Of Notes Convertible Into The Common Stock DescriptionOfNotesConvertibleIntoTheCommonStock	The notes are convertible into the common stock of the Company at any time at a conversion price equal to (i) 50% of the lowest closing bid price of our common stock for the twenty days prior to conversion or (ii) fixed price of $0.15 or $0.30 per share.
CY2021Q2	vism	Aged Debt Totaling AgedDebtTotaling	787272	usd
CY2022Q2	vism	Common Stock Shares Outstanding1 CommonStockSharesOutstanding1	2896396	shares
CY2022Q2	vism	Restricted Stock Unvested Shares RestrictedStockUnvestedShares	7408	shares
CY2022	vism	Reverse Stock Split Outstanding Common Shares ReverseStockSplitOutstandingCommonShares	3916144800	shares
CY2022Q2	vism	Accrued Interest Expense AccruedInterestExpense	385803	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	401469	usd
CY2022Q2	vism	Convertible Debt1 ConvertibleDebt1	787272	usd
CY2022	vism	Debt Conversion Converted Instrument Shares Issued16 C DebtConversionConvertedInstrumentSharesIssued16C	146701	shares
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	5.66
CY2022	vism	Issuance Of Convertible Notes Payable IssuanceOfConvertibleNotesPayable	86667	usd
CY2022	vism	Relative Fair Value RelativeFairValue	236567	usd
CY2022	vism	Beneficial Conversion Feature Of Notes Payable BeneficialConversionFeatureOfNotesPayable	239564	usd
CY2022Q2	vism	Promissory Notes PromissoryNotes	205000	usd
CY2021Q2	vism	Promissory Notes PromissoryNotes	411748	usd
CY2021Q2	us-gaap	Interest Payable Current InterestPayableCurrent	366149	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	133994	usd
CY2022	vism	Payments Of Accrued Interest PaymentsOfAccruedInterest	-39431	usd
CY2022	vism	Conversion Of Accrued Interest Into Common Stock ConversionOfAccruedInterestIntoCommonStock	-56000	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	404712	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	133994	usd
CY2022	vism	Amortization Of Debt Discount Premium1 AmortizationOfDebtDiscountPremium1	571081	usd
CY2022	vism	Interest Expense Other1 InterestExpenseOther1	705075	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2903804	shares
CY2022	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	146701	shares
CY2022	vism	Shares Issued For Conversion Of Notes Payable Amount SharesIssuedForConversionOfNotesPayableAmount	828797	usd
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	5.66
CY2022	vism	Fair Value Shares Issued FairValueSharesIssued	2422722	usd
CY2022	vism	Shares Issued As Warrent Shares SharesIssuedAsWarrentShares	4881	shares
CY2022Q2	vism	Waarant Price Per Share WaarantPricePerShare	0.0001
CY2022	vism	Common Stock Issued To Litigation Of Settlement CommonStockIssuedToLitigationOfSettlement	44444	shares
CY2022	vism	Common Stock Issued To Litigation Of Settlement Amount CommonStockIssuedToLitigationOfSettlementAmount	108000	usd
CY2022	vism	Gain On Settlement Of Litigation GainOnSettlementOfLitigation	39965	usd
CY2021Q2	vism	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	5049	shares
CY2022Q2	vism	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	5049	shares
CY2022Q2	vism	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice	14.85
CY2021Q2	vism	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice	14.85
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	5049	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y9M10D
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	14.85
CY2022Q2	vism	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	5049	shares
CY2022Q2	vism	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice	14.85
CY2022Q2	vism	Preferred Stock Has A Stated Value PreferredStockHasAStatedValue	0.001
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	11852	shares
CY2022	vism	Fair Value Of Shares FairValueOfShares	0.00
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	143529	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18554	usd
CY2022Q2	vism	Unrecognized Pre Tax Non Cash Compensation Expense UnrecognizedPreTaxNonCashCompensationExpense	0	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2021	vism	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y10M2D
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7768000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7245000	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11852	shares
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	20.25
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	11852	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.25
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	9630	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	18.69
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	0	usd
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2222	shares
CY2022Q2	vism	Weighted Average Exercie Price Ending WeightedAverageExerciePriceEnding	27.00
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11852	shares
CY2021Q2	vism	Weighted Average Exercie Price Ending WeightedAverageExerciePriceEnding	20.25
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q2	vism	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber1	2222	shares
CY2022Q2	vism	Options Exercisable Period Ending OptionsExercisablePeriodEnding	27.00
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2021Q2	vism	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber1	1173	shares
CY2021Q2	vism	Options Exercisable Period Ending OptionsExercisablePeriodEnding	20.25
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2222	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M2D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	27.00
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2222	shares
CY2022	vism	Weighted Averaged Exercise Price Vested WeightedAveragedExercisePriceVested	27.00
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y10M2D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2222	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M2D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	27.00
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2222	shares
CY2022	vism	Weighted Averaged Exercise Price Vested WeightedAveragedExercisePriceVested	27.00
CY2021Q2	vism	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber1	97778	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	15.53
CY2020Q2	vism	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber1	494	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	81.00
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	41481	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.66
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	146667	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	15.53
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	8025	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	10.80
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	123827	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	14.85
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	49383	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	15.53
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	7407	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	13.50
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	97778	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	15.53
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	91800	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y6M
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.217	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.217	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.036	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.036	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.086	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.086	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.167	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.167	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	usd
CY2021Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7768000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7245000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7768000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7245000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	36900000	usd
CY2022	vism	Net Operating Loss Carryforwards Expiration Date NetOperatingLossCarryforwardsExpirationDate	expire through fiscal years ending 2040
CY2022	vism	Percent Of Change In Ownership PercentOfChangeInOwnership	0.50	pure
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7768000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7245000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	523000	usd
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.35	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.217	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.254	pure
CY2022Q2	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	0	usd
CY2021	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	1481	usd

Files In Submission

Name	View Source	Status
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vism-20220630.xsd	Edgar Link	pending
vism_10k.htm	Edgar Link	pending
vism_10kimg1.jpg	Edgar Link	pending
vism_10kimg2.jpg	Edgar Link	pending
vism_10kimg3.jpg	Edgar Link	pending
vism_ex211.htm	Edgar Link	pending
vism_ex311.htm	Edgar Link	pending
vism_ex312.htm	Edgar Link	pending
vism_ex321.htm	Edgar Link	pending
vism_ex322.htm	Edgar Link	pending
vism-20220630_pre.xml	Edgar Link	unprocessable
vism-20220630_def.xml	Edgar Link	unprocessable
vism-20220630_cal.xml	Edgar Link	unprocessable
vism-20220630_lab.xml	Edgar Link	unprocessable
vism_10k_htm.xml	Edgar Link	completed
0001654954-22-013289-index-headers.html	Edgar Link	pending
0001654954-22-013289-index.html	Edgar Link	pending
0001654954-22-013289.txt	Edgar Link	pending
0001654954-22-013289-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VISM
VISIUM TECHNOLOGIES, INC. Stock $vism

2022 Q3 Form 10-K Financial Statement

#000165495422013289 Filed on October 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VISM VISIUM TECHNOLOGIES, INC. Stock $vism

2022 Q3 Form 10-K Financial Statement

#000165495422013289 Filed on October 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VISM
VISIUM TECHNOLOGIES, INC. Stock $vism